The market has soared to begin 2013 with many biotech companies leading the way. That should be no surprise given the massive swings that companies can make in just a week's time. Fortunately for some lucky investors, several biotech stocks have absolutely destroyed the returns of the broader market. In the following video, Fool contributor Maxx Chatsko reviews the five hottest biotech stocks through the first five months of the year and tells investors if things are about to cool down any time soon.
Obamacare will undoubtedly have far-reaching effects on stocks in the health care world and beyond. The Motley Fool's new free report, "Everything You Need to Know About Obamacare," lets you know how your health insurance, your taxes, and your portfolio will be affected. Click here to read more.
The article 5 Best Biotechs of 2013 originally appeared on Fool.com.
Fool contributor Maxx Chatsko has no position in any stocks mentioned. The Motley Fool recommends Vertex Pharmaceuticals. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.